Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mark Klaassen

Orthopaedic Surgery Elkhart, IN Medical Doctor

NPI 1053325589 CMS profile 320167

2310 California Road, Ste A, Elkhart, IN 46514

Open in the dashboard

General payments

$1,320,813

766 records reported · program years 2019–2025

Research payments

$14,710

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$796,241

4 holdings reported · through program year 2025

Research they led as principal investigator

$76,675 paid to institutions, not to them · program years 2019–2021

Through program year 2025, Mark Klaassen of Elkhart, IN is reported in the CMS Open Payments database as having received $1,320,813 across 766 general payments and $14,710 in research payments paid to them. Separately, studies naming them as principal investigator received $76,675 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $796,241 across 4 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

12 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $73,996 38
2024 General $54,133 42
2023 General $118,241 69
2022 General $639,890 96
2021 General $124,465 134
2021 Research $4,410 1
2020 General $122,860 147
2019 General $187,228 240
2019 Research $10,300 1
2021 Ownership $595,320 2
2020 Ownership $100,000 1
2019 Ownership $100,922 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mark Klaassen
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Mark Klaassen were reported at $73,996. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Mark Klaassen Orthopaedic Surgery median Middle half National median
2019 $187,228 $644 $140–$2,844 $163
2020 $122,860 $312 $75–$1,860 $114
2021 $124,465 $520 $117–$2,495 $132
2022 $639,890 $598 $128–$2,731 $149
2023 $118,241 $461 $128–$2,264 $160
2024 $54,133 $497 $134–$2,475 $164
2025 $73,996 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $616,606 62 payments
  2. Zimmer Biomet Holdings, Inc. $292,080 469 payments
  3. Medacta USA, Inc. $279,364 77 payments
  4. Exactech, Inc. $100,395 92 payments
  5. Arthrex, Inc. $11,216 4 payments
  6. Encore Medical, LP $8,443 8 payments
  7. OrthoSensor Inc. $5,066 4 payments
  8. Stryker Corporation $2,766 22 payments
  9. Engage Uni, LLC $1,939 5 payments
  10. Heron Therapeutics, Inc. $1,500 1 payment
  11. Other $1,437 22 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Acquisitions $564,102 5 payments
  2. Consulting Fee $378,989 227 payments
  3. Royalty or License $264,249 58 payments
  4. Travel and Lodging $56,206 182 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $32,375 7 payments
  6. Food and Beverage $17,348 272 payments
  7. Education $7,431 14 payments
  8. Gift $114 1 payment
Products named General payments · program years 2019–2025
  1. Engage Partial Knee System $597,687 36 payments
  2. GMK SPHERE Knee $175,178 38 payments
  3. OPTETRAK $67,979 48 payments
  4. Oxford $49,616 58 payments
  5. GMK Sphere Revision System $38,876 18 payments
  6. JOURNEY II $37,592 16 payments
  7. GMK Sphere Orthopedics/Orthopedic Surgery $33,687 4 payments
  8. REAL INTELLIGENCE $31,492 25 payments
  9. PD-Knee-New Product $31,136 57 payments
  10. Oxford-Knees $29,523 35 payments
  11. Other $337,930 492 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $14,710 2 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

30

Median for Orthopaedic Surgery: 30

Drug cost

$70

Median for Orthopaedic Surgery: $176

Branded share of claims

0%

Median for Orthopaedic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 30 $70

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,233 Part D prescribers listed as Orthopaedic Surgery; they describe a distribution and say nothing about conduct.

Records

768 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record